No. Special, December 2005
Index
- Symposium: Proceedings of The Genomics Revolution? Science, Law and Policy
- Population Health and the Influence of Medical and Scientific Advances
- Overview of Law and Policy Challenges
- Risk Prediction for Common Diseases
- Taking Genomics to the BioBank: Access to Human Biological Samples and Medical Information
- Intellectual Property/Ownership Issues
- Population Participation and Other Factors that Impact the Compilation and the Utility of Resulting Databases
- FDA Policy on Pharmacogenomic Data in Drug Development
- Commercialization Considerations for Individualized Diagnostic and Drug Therapies Resulting from Pharmacogenomics
- Liability Issues in Pharmacogenomics
- Implications for Existing Law/Regulations
- Race, Genetic Variation, and the Haplotype Mapping Project